Weekly paclitaxel may improve locoregional recurrence by decreasing interstitial fluid pressure in operable node-positive breast cancer patients.
Altundag
Kadri
K
Altundag
Ozden
O
Boruban
Cem
C
Altundag
Muzaffer B
MB
Turen
Selahattin
S
D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms; D004305:Dose-Response Relationship, Drug; D045604:Extracellular Fluid / Q000187:drug effects*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000517:prevention & control*; D017239:Paclitaxel / Q000494:pharmacology* / Q000627:therapeutic use; D011312:Pressure
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel